Juan Uribe is facing every parent’s worst nightmare: a ticking clock to save his son’s life. Fifteen-year-old Max, a vibrant high school freshman, has just weeks before he needs hospitalization for a rare and rapidly worsening blood disorder.
The first hint of trouble appeared when Max was only six, with persistently abnormal blood counts. Initially dismissed as a lingering viral infection, the numbers never fully recovered, a subtle warning that went unheeded for years.
In December 2024, the diagnosis came: clonal cytopenia, a condition affecting both blood and bone marrow. All three critical blood counts – red cells, white cells, and platelets – were dangerously low, signaling a deeper, more serious problem.
Further testing in August 2025 revealed a terrifying progression. Max is now on a direct path to bone marrow failure, creating an urgent and desperate need for a stem cell transplant. Without it, his condition will inevitably worsen.
The looming threat is not just the current illness, but the potential for it to transform into myelodysplastic syndrome (MDS), a form of blood cancer, and ultimately, acute myeloid leukemia (AML). Time is no longer a luxury; it’s a critical resource dwindling with each passing day.
Finding a suitable donor hinges on a precise match of HLA markers – proteins on the surface of cells that determine compatibility. The closer the match, the lower the risk of rejection and life-threatening complications.
Unfortunately, finding a match is significantly harder for individuals with diverse ethnic backgrounds. While a Caucasian patient has a roughly 73% chance of finding a compatible donor, that number plummets to 49% for Hispanic/Latino, 29% for Black, and even lower for those with mixed ancestry.
Max’s heritage presents a unique and devastating challenge. His father is Colombian, while his mother’s ancestry is a complex blend of Italian, British, and German. This “very rare combination” makes finding a perfect match exponentially more difficult.
Recent blood work confirmed the frightening reality: Max’s counts are plummeting, and the disease is visibly manifesting. The urgency has reached a critical point, demanding immediate action and a widespread search for a life-saving donor.
If a fully matched donor isn’t found before Max’s scheduled hospitalization in May, doctors will be forced to consider a partial match. While a partial match is better than nothing, it carries significantly higher risks, including a lower survival rate and the potential for graft versus host disease (GVHD).
GVHD occurs when the donor cells attack the recipient’s body, leading to severe complications. To mitigate this risk, Max would require prolonged chemotherapy and immunosuppressant treatment, further weakening his already compromised immune system.
A simple cheek swab is all it takes to potentially save a young man’s life. A test kit can determine HLA compatibility and offer Max a chance at a future filled with the passions he loves – competitive tennis and varsity wrestling.
Every potential donor represents a beacon of hope in this desperate search. The more people who get tested, the greater the chance of finding the perfect match that Max so desperately needs.
